Systematic Analyses of Genes Associated with Radiosensitizing Effect by Celecoxib, a Specific Cyclooxygenase-2 Inhibitor-Reference-Cited by-同舟云学术

Systematic Analyses of Genes Associated with Radiosensitizing Effect by Celecoxib, a Specific Cyclooxygenase-2 Inhibitor

Published:2011 Issue:6 Volume:52 Page:752-765
ISSN:0449-3060
Container-title:Journal of Radiation Research
language:en
Short-container-title:JRR

Author:

KIM Young-Mee,SHIN You Keun,JUN Hyun Jung,RHA Sun Young,PYO Hongryull

Publisher

Oxford University Press (OUP)

Subject

Health, Toxicology and Mutagenesis,Radiology, Nuclear Medicine and imaging,Radiation

Link

http://academic.oup.com/jrr/article-pdf/52/6/752/2718414/jrr-52-752.pdf

Reference37 articles.

1. 1. Rao P and Knaus E-E (2008) Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J Pharm Pharm Sci 11: 81s-110s.

2. 2. Lou J, et al (2006) Proteomic profiling identifies cyclooxygenase-2-independent global proteomic changes by celecoxib in colorectal cancer cells. Cancer Epidemiol Biomarkers Prev 15: 1598-1606.

3. 3. Huang R-H, Chai J and Tarnawski AS (2006) Identification of specific genes and pathways involved in NSAIDs-induced apoptosis of human colon cancer cells. World J Gastroenterol 12: 6446-6452.

4. 4. Glebov O-K, et al (2006) Celecoxib treatment alters the gene expression profile of normal colonic mucosa. Cancer Epidemiol Biomarkers Prev 15: 1382-1391.

5. 5. Grosch S, et al (2006) Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors. J Natl Cancer Inst 98: 736-747.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression and clinical significance of cyclooxygenase 2 and survivin in human gliomas;Oncology Letters;2017-05-31

2. Celecoxib mitigates genotoxicity induced by ionizing radiation in human blood lymphocytes;Research in Pharmaceutical Sciences;2017

3. Genomic and Histopathological Tissue Biomarkers That Predict Radiotherapy Response in Localised Prostate Cancer;BioMed Research International;2015

4. Cervical Cancer: Are There Potential New Targets? An Update on Preclinical and Clinical Results;Current Drug Targets;2014-11-07

5. A Tissue Biomarker–Based Model That Identifies Patients with a High Risk of Distant Metastasis and Differential Survival by Length of Androgen Deprivation Therapy in RTOG Protocol 92-02;Clinical Cancer Research;2014-10-07